Synapse - American Association for Clinical Chemistry

Results (152)

Analytical validation of the GeXP analyzer and identification of a gene signature biontarker for distinguishing cancer and non-cancer cell types

Meeting Abstract

Rai, A. J.; Anand, A.; Fleisher, M.
Clinical Chemistry (2007)

Fulltext@MSK | Save

Changes in serum HER-2/neu levels of > 20% from baseline is associated with favorable clinical outcomes to Trastuzumab-based therapy

Meeting Abstract

Price, C.; Ali, S.; Harris, L.; Brault, D.; Kostler, W.; Luftner, D.; Fornier, M.; Leitzel, K.; Lotz, J. P.; Pichon, M.; more...
Clinical Chemistry (2007)

Fulltext@MSK | Save

Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer

Journal Article

Steuber, T.; Vickers, A. J.; Serio, A. M.; Vaisanen, V.; Haese, A.; Kim, P.; Eastham, J. A.; Scardino, P. T.; Huland, H.; Lilja, H.
Clinical Chemistry (2007)

Fulltext@MSK | Save

Proteomic analysis of haptolobin alpha-subunit isoelectric variants as ovarian cancer biomarkers using narrow range two dimensional gel electrophoresis and immunoblotting

Meeting Abstract

Rai, A. J.; Sokoll, L. J.; Chan, D. W.
Clinical Chemistry (2006)

Fulltext@MSK | Save

Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 °C

Journal Article

Ulmert, D.; Becker, C.; Nilsson, J. Å; Piironen, T.; Björk, T.; Hugosson, J.; Berglund, G.; Lilja, H.
Clinical Chemistry (2006)

Fulltext@MSK | Save

Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum

Journal Article

Pilronen, T.; Haese, A.; Huland, H.; Steuber, T.; Christensen, I. J.; Brünner, N.; Danø, K.; Høyer-Hansen, G.; Lilja, H.
Clinical Chemistry (2006)

Fulltext@MSK | Save

Serum HER-2/neu has clinical utility in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzamab-based therapies